AbbVie Inc. v. Hetero USA, Inc. et al

1:25-cv-00190 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Maryellen Noreika
Filed Feb. 14, 2025
Case Flags ANDA and PATENT
Nature of Suit 835 Patent - Abbreviated New Drug Application (ANDA)
Cause 35:271 Patent Infringement
Jury Demand None
The docket is incomplete. Sign up for verified information.
Filing Date # Docket Text
3/14/2025SO ORDERED, -District Court Pro Hac Vice Fee - 03 Attorneys Credit Card Payment
3/14/2025Appear Pro Hac Vice
2/25/2025Waiver of Service Executed - 60 day ddl
2/25/2025Waiver of Service Executed - 60 day ddl
2/25/2025Waiver of Service Executed - 60 day ddl
2/19/2025Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms) (Entered: 02/19/2025)
2/18/2025CORRECTING ENTRY: The main document and attachment documents at D.I. 6 have been modified and replaced to reflect the correct day of issuance. (cdd) (Entered: 02/18/2025)
2/14/2025Summons Issued as to Hetero Labs Limited on 2/18/2025; Hetero Labs Limited Unit-V on 2/18/2025; Hetero USA, Inc. on 2/18/2025; Hoster Labs Private Limited on 2/18/2025. (Attachments: # 1 Summons Issued, # 2 Summons Issued, # 3 Summons Issued)(cdd). (Entered: 02/18/2025)
2/14/2025 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc. (cdd) (Entered: 02/18/2025)
2/14/2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,607,411 B2; 11,564,922 B2. (cdd) (Entered: 02/18/2025)
2/14/2025 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/6/2025. Date of Expiration of Patent: 3/9/2038.Thirty Month Stay Deadline: Not earlier than 8/6/2027. (cdd) Modified on 2/18/2025 (nms). (Entered: 02/18/2025)
2/14/2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) (Entered: 02/18/2025)
2/14/2025COMPLAINT against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc., Hoster Labs Private Limited (Filing fee $ 405, receipt number ADEDC-4615717) - filed by AbbVie Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(cdd) (Entered: 02/18/2025)